Status:
COMPLETED
Chemotherapy With DNA Damaging Agents In Colorectal Cancer
Lead Sponsor:
Centro Hospitalar Nordeste
Conditions:
Colorectal Cancer
Eligibility:
All Genders
40-90 years
Phase:
PHASE1
Brief Summary
Chemotherapy Treatment alone with DNA damaging drugs might be as effective as chemotherapy combined with surgery in colorectal cancer (CRC) avoiding surgery complications.
Eligibility Criteria
Inclusion
- \- patients that did not underwent surgery
Exclusion
- \- patients that underwent surgery
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01456923
Last Update
October 21 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.